Literature DB >> 24118291

Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.

P Vironneau1, R Kania, G Morizot, C Elie, D Garcia-Hermoso, P Herman, O Lortholary, F Lanternier.   

Abstract

Surgery and antifungals are the reference standard for rhino-orbito-cerebral mucormycosis (ROCM) treatment. The impact of local control on survival of 22 consecutive ROCM adults was studied on day 90: none vs. 75% died, respectively, with or without local control (p <0.0001). Hence, repeated surgical procedures are recommended to achieve local control of ROCM.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Local control; mucormycosis; necrosis; sinusitis; surgery

Mesh：

Substances：

Year:  2013        PMID： 24118291     DOI： 10.1111/1469-0691.12408

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  15 in total

1.  Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series.

Authors:  Maria N Chitasombat; Pimjai Niparuck
Journal:  Infect Dis Rep       Date:  2018-09-25

2.  Imaging Patterns of Rhino-Orbital-Cerebral Mucormycosis in Immunocompromised Patients : When to Suspect Complicated Mucormycosis.

Authors:  Peter Raab; Ludwig Sedlacek; Stefanie Buchholz; Stefan Stolle; H Lanfermann
Journal:  Clin Neuroradiol       Date:  2017-10-12       Impact factor: 3.649

Review 3.  Invasive mold infections in solid organ transplant recipients.

Authors:  Yoann Crabol; Olivier Lortholary
Journal:  Scientifica (Cairo)       Date:  2014-11-23

Review 4.  Neuroinfections caused by fungi.

Authors:  Katarzyna Góralska; Joanna Blaszkowska; Magdalena Dzikowiec
Journal:  Infection       Date:  2018-05-21       Impact factor: 3.553

Review 5.  Therapy of Mucormycosis.

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Amalia Anastasopoulou; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2018-07-31

6.  [Mucormycosis in patients with hematological diseases: seven cases reports and literature review].

Authors:  Y Qi; M F Zhao; Q Deng; L Geng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-11-14

7.  Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.

Authors:  Sarah Elitzur; Salvador Fischer; Nira Arad-Cohen; Assaf Barg; Miriam Ben-Harosh; Dana Danino; Ronit Elhasid; Aharon Gefen; Gil Gilad; Itzhak Levy; Yael Shachor-Meyouhas; Sigal Weinreb; Shai Izraeli; Shlomit Barzilai-Birenboim
Journal:  J Fungi (Basel)       Date:  2021-02-25

8.  Medical and surgical treatment of rhino-orbital-cerebral mucormycosis in a child with leukemia.

Authors:  Mette Levinsen; Jens Folke Kiilgaard; Carsten Thomsen; Steffen Heegaard; Kamilla Rothe Nissen
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-16

Review 9.  Recent advances in the understanding and management of mucormycosis.

Authors:  Benoit Pilmis; Alexandre Alanio; Olivier Lortholary; Fanny Lanternier
Journal:  F1000Res       Date:  2018-09-07

10.  Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis.

Authors:  Malene Risum; Jannik Helweg-Larsen; Søren Lykke Petersen; Peter Kampmann; Ulrik Malthe Overgaard; Daniel El Fassi; Ove Juul Nielsen; Mette Brabrand; Niclas Rubek; Lars Munksgaard; Marianne Tang Severinsen; Bendt Nielsen; Jan Berg Gertsen; Åsa Gylfe; Ulla Hjort; Angeliki Vourtsi; Rasmus Krøger Hare; Maiken Cavling Arendrup
Journal:  J Fungi (Basel)       Date:  2020-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.